| Chris Byers, MA, CCC-SLP | |
|
5012 Chesebro Rd, Suite 101, Agoura Hills, CA 91301-2272 | |
| (818) 419-1123 | |
| Not Available |
| Full Name | Chris Byers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5012 Chesebro Rd, Agoura Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154539575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP10464 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chris Byers, MA, CCC-SLP 5012 Chesebro Rd, Suite 101, Agoura Hills, CA 91301-2272 Ph: (818) 419-1123 | Chris Byers, MA, CCC-SLP 5012 Chesebro Rd, Suite 101, Agoura Hills, CA 91301-2272 Ph: (818) 419-1123 |
News Archive
It appears that living in a poor neighborhood with a high concentration of African Americans is associated with greater alcohol availability and promotion - especially malt liquor - according to a recent study by University of Minnesota researchers.
Researchers at Rutgers School of Dental Medicine have found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in a human cell.
As part of its ongoing efforts to alleviate human suffering, the American relief organization, Life for Relief and Development (Life) in partnership with another humanitarian organization, will be providing two major shipments of children's medicines with a value of over two and half million dollars to hospitals and clinics in Pakistan.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
Prophylactic use of the drug haloperidol does not help to prevent delirium in intensive care patients or improve their chances of survival. Therefore, there is no reason anymore to administer the drug as a preventive measure to reduce the burden of delirium.
› Verified 1 days ago
Taryn Reitman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4258 Via Mira Monte, Agoura Hills, CA 91301 Phone: 818-309-3420 | |
Denise Zweig, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5627 Kanan Rd Ste 184, Agoura Hills, CA 91301 Phone: 805-262-7809 | |
Tina Valcarenghi, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5236 Colodny Dr, Suite #205, Agoura Hills, CA 91301 Phone: 818-865-8135 | |
Amy Simon-weiner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 Fairgrange Dr, Agoura Hills, CA 91301 Phone: 818-991-4314 | |
Siri Ilene Woods, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29120 Quail Run Dr, Agoura Hills, CA 91301 Phone: 818-631-8410 | |
Vicki Claymon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6314 Kerryhill Ct, Agoura Hills, CA 91301 Phone: 818-268-7693 |